Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Discharge Education in Diabetic Surgical Patients

NCT06777836 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-02-01
Last updated
2025-01-16

Condition(s) studied

To Examine the Effects of Diabetes-based Personalised Discharge Education Given to Diabetic Surgical Patients on SatisfactionTo Examine the Effects of Diabetes-based Personalised Discharge Education Given to Diabetic Surgical Patients on Diabetes Empowerment

Investigational drug(s) / intervention(s)

Personalised Discharge training

Personalised Discharge training: Discharge education also contributes to the empowerment of diabetic surgery patients in diabetes management. During the training process, patients will be informed about blood glucose control, diet, exercise and medication management.

Study summary

In the literature, it is seen that the discharge education given to patients with diabetes is especially focused on the effects of blood glucose control and self-efficacy, and there is no study examining the effects of discharge education on diabetes empowerment with a more general perspective in diabetes patients in surgical processes. In this context, the study was designed to examine the effects of diabetes-based personalised discharge education given to surgical patients on satisfaction and diabetes empowerment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * He's had an operation, * Over 18 years old, * Diagnosed with diabetes, * Conscious patients returning to the clinic after surgery, not intubated Exclusion Criteria: * He's unconscious, * Referral to intensive care, * Patients who do not agree to participate in the study will be excluded from the study.

Primary outcome measure(s)

  • Satisfaction with Discharge Training — through study completion, an average of 1 year
    It will be measured with the Discharge Training Satisfaction Scale Specific to Surgical Patients. Satisfaction will be measured with the 'Discharge Training Satisfaction Scale'. It consists of 21 items in a 5-point Likert scale. The scale does not contain negative items. The lowest score of 21 points and the highest score of 105 points can be obtained from the scale.
  • diabetes empowerment — through study completion, an average of 1 year
    The ability to manage the disease will be measured with the Diabetes Empowerment Scale. There are 28 items in Diabetes Empowerment Scale. Five-point Likert type (1: Strongly disagree, 5: Strongly agree), items 18,20,21,22,23,24,25,26 and 27 of this scale are under the sub-dimension of 'Self-awareness-managing psychological aspects of illness'; items 1,2,3,4,15,16,17 and 19 are under the sub-dimension of 'Ability to achieve goals'; items 5,6,7,8,9,10,11,12,13 and 14 are under the sub-dimension of 'Ability to set goals'. The minimum score of the scale is 28 and the maximum score is 140. A score between 28-65 points indicates a low level of resilience, 66-103 indicates a medium level, and 104-140 indicates a high level of resilience.

Trial sites (1)

FacilityCityRegionStatus
Abant Izzet Baysal University Faculty of Health Science Bolu Merkez
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06777836 on ClinicalTrials.gov ↗ ← All trials in Turkey